【表紙】

 

【提出書類】

有価証券報告書

【根拠条文】

金融商品取引法第24条第1項

【提出先】

関東財務局長

【提出日】

2024年3月26日

【事業年度】

第20期(自 2023年1月1日 至 2023年12月31日)

【会社名】

株式会社カイオム・バイオサイエンス

【英訳名】

Chiome Bioscience Inc.

【代表者の役職氏名】

代表取締役社長 小林 茂

【本店の所在の場所】

東京都渋谷区本町三丁目12番1号

【電話番号】

03-6383-3561

【事務連絡者氏名】

取締役経営企画室長 美女平 在彦

【最寄りの連絡場所】

東京都渋谷区本町三丁目12番1号

【電話番号】

03-6383-3561

【事務連絡者氏名】

取締役経営企画室長 美女平 在彦

【縦覧に供する場所】

株式会社東京証券取引所

(東京都中央区日本橋兜町2番1号)

 

E26096 45830 株式会社カイオム・バイオサイエンス Chiome Bioscience Inc. 企業内容等の開示に関する内閣府令 第三号様式 Japan GAAP false CTE 2023-01-01 2023-12-31 FY 2023-12-31 2022-01-01 2022-12-31 2022-12-31 1 false false false E26096-000 2023-12-31 jpcrp_cor:OrdinaryShareMember E26096-000 2023-12-31 jpcrp_cor:SharesWithNoVotingRightsMember E26096-000 2023-12-31 jpcrp_cor:SharesWithRestrictedVotingRightsTreasurySharesEtcMember E26096-000 2023-12-31 jpcrp_cor:SharesWithRestrictedVotingRightsOtherMember E26096-000 2023-12-31 jpcrp_cor:SharesWithFullVotingRightsTreasurySharesEtcMember E26096-000 2023-12-31 jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember E26096-000 2023-12-31 jpcrp_cor:SharesWithFullVotingRightsOtherMember E26096-000 2023-12-31 jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsOtherMember E26096-000 2023-12-31 jpcrp_cor:SharesLessThanOneUnitMember E26096-000 2023-12-31 jpcrp_cor:OrdinarySharesSharesLessThanOneUnitMember E26096-000 2023-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:CorporateSharedMember E26096-000 2023-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReconcilingItemsMember E26096-000 2023-12-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jpcrp_cor:ReportableSegmentsMember jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReconcilingItemsMember E26096-000 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:SubscriptionRightsToSharesMember E26096-000 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalStockMember E26096-000 2023-12-31 jpcrp030000-asr_E26096-000:DrugDiscoverySupportReportableSegmentsMember jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jpcrp030000-asr_E26096-000:DrugDiscoverySupportReportableSegmentsMember jppfs_cor:NonConsolidatedMember E26096-000 2022-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E26096-000:DrugDiscoverySupportReportableSegmentsMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E26096-000:DrugDiscoverySupportReportableSegmentsMember E26096-000 2023-12-31 jpcrp030000-asr_E26096-000:DrugDiscoveryAndDevelopmentReportableSegmentsMember jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jpcrp030000-asr_E26096-000:DrugDiscoveryAndDevelopmentReportableSegmentsMember jppfs_cor:NonConsolidatedMember E26096-000 2022-12-31 jpcrp030000-asr_E26096-000:DrugDiscoveryAndDevelopmentReportableSegmentsMember jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:TotalOfReportableSegmentsAndOthersMember E26096-000 2022-12-31 jppfs_cor:LegalCapitalSurplusMember jppfs_cor:NonConsolidatedMember E26096-000 2022-12-31 jppfs_cor:CapitalSurplusMember jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 E26096-000 2022-01-01 2022-12-31 E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:KobayashiShigeruMember E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:BijohiraArihikoMember E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:KubotaHaruhisaMember E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:YamakawaYoshiyukiMember E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:TaokaShoseiMember E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:KoikeMasamichiMember E26096-000 2024-03-26 E26096-000 2023-12-31 E26096-000 2024-03-26 jpcrp_cor:OrdinaryShareMember E26096-000 2022-12-31 jpcrp_cor:TotalOfReportableSegmentsAndOthersMember jppfs_cor:NonConsolidatedMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReconcilingItemsMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jpcrp_cor:No1MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No2MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No3MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No4MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No5MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No6MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No7MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No8MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No9MajorShareholdersMember E26096-000 2023-12-31 jpcrp_cor:No10MajorShareholdersMember E26096-000 2022-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2021-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2021-01-01 2021-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2020-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jpcrp_cor:DirectorsExcludingOutsideDirectorsMember E26096-000 2023-01-01 2023-12-31 jpcrp_cor:CorporateAuditorsExcludingOutsideCorporateAuditorsMember E26096-000 2023-01-01 2023-12-31 jpcrp_cor:OutsideDirectorsAndOtherOfficersMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jpcrp030000-asr_E26096-000:DrugDiscoveryAndDevelopmentReportableSegmentsMember E26096-000 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember E26096-000 2021-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:TreasuryStockMember E26096-000 2024-03-26 jpcrp_cor:Row8Member E26096-000 2024-03-26 jpcrp_cor:Row7Member E26096-000 2024-03-26 jpcrp_cor:Row6Member E26096-000 2024-03-26 jpcrp_cor:Row5Member E26096-000 2024-03-26 jpcrp_cor:Row4Member E26096-000 2024-03-26 jpcrp_cor:Row3Member E26096-000 2024-03-26 jpcrp_cor:Row2Member E26096-000 2024-03-26 jpcrp_cor:Row1Member E26096-000 2023-12-31 jppfs_cor:ShareholdersEquityMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jppfs_cor:CapitalStockMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E26096-000 2023-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E26096-000 2023-12-31 jppfs_cor:RetainedEarningsMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jppfs_cor:RetainedEarningsBroughtForwardMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:SubscriptionRightsToSharesMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:CapitalStockMember jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:CapitalSurplusMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:RetainedEarningsMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jpcrp_cor:Row1Member E26096-000 2019-01-01 2019-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2021-12-31 jppfs_cor:CapitalStockMember jppfs_cor:NonConsolidatedMember E26096-000 2021-12-31 jppfs_cor:LegalCapitalSurplusMember jppfs_cor:NonConsolidatedMember E26096-000 2021-12-31 jppfs_cor:CapitalSurplusMember jppfs_cor:NonConsolidatedMember E26096-000 2023-12-31 jppfs_cor:TreasuryStockMember jppfs_cor:NonConsolidatedMember E26096-000 2023-01-01 2023-12-31 jppfs_cor:TreasuryStockMember jppfs_cor:NonConsolidatedMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:LegalCapitalSurplusMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:CapitalSurplusMember jppfs_cor:NonConsolidatedMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsBroughtForwardMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:RetainedEarningsMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:ShareholdersEquityMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jppfs_cor:SubscriptionRightsToSharesMember E26096-000 2022-12-31 jppfs_cor:RetainedEarningsMember jppfs_cor:NonConsolidatedMember E26096-000 2022-12-31 jppfs_cor:ShareholdersEquityMember jppfs_cor:NonConsolidatedMember E26096-000 2020-01-01 2020-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2022-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:ReconcilingItemsMember E26096-000 2021-12-31 jppfs_cor:RetainedEarningsBroughtForwardMember jppfs_cor:NonConsolidatedMember E26096-000 2021-12-31 jppfs_cor:RetainedEarningsMember jppfs_cor:NonConsolidatedMember E26096-000 2021-12-31 jppfs_cor:ShareholdersEquityMember jppfs_cor:NonConsolidatedMember E26096-000 2021-12-31 jppfs_cor:SubscriptionRightsToSharesMember jppfs_cor:NonConsolidatedMember E26096-000 2019-12-31 jppfs_cor:NonConsolidatedMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:CapitalStockMember jppfs_cor:NonConsolidatedMember E26096-000 2022-12-31 jppfs_cor:RetainedEarningsBroughtForwardMember jppfs_cor:NonConsolidatedMember E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:SakamotoNiroMember E26096-000 2022-01-01 2022-12-31 jppfs_cor:NonConsolidatedMember jpcrp_cor:TotalOfReportableSegmentsAndOthersMember E26096-000 2024-03-26 jpcrp030000-asr_E26096-000:FuruyaAkiyukiMember iso4217:JPY xbrli:shares xbrli:shares xbrli:pure iso4217:JPY